Dr Sarita Shrivastva – Oncologist

Dr. Sarita Shrivastva is a highly esteemed Medical and Hemato Oncologist renowned for her expertise, currently practicing at the prestigious Medicover Cancer Institute in Hitech City. With a commendable tenure of 15 years in the field of Medical Oncology, she brings a wealth of experience to her practice. Having served as a distinguished Medical Oncologist across various cities in India, Dr. Shrivastva has garnered a reputation for her exceptional patient care and clinical acumen. Her dedication to advancing cancer treatment and her commitment to patient well-being make her a trusted figure in the medical community. 

Specializations

Dr. Sarita Shrivastva performs major interventions in the following –

• Medical oncology

Education and Qualifications

• D.M. Medical Oncology (Sep 2017 – Sep 2020) – Nizam’s Institute of Medical Sciences(NIMS), Hyderabad
• M.D. Radiation Oncology (Aug 2013 – July 2016) – MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad
• M.B.B.S (2004 – 2009) – Osmania Medical College, Hyderabad

Work Experience

• He worked as a clinical consultant and hemato oncologist at the Cion Cancer Clinic

Awards & Achievements

• Winner of 42nd ICON National Level Quiz, Mar’20, Hyderabad
• Winner of 41st ICON National Quiz, Sep’19, Ahmedabad
• Winner of ICON’s 40th National Quiz, Mar’19, Kolkata
• National Poster Presentation Winners
• ISMPOCON Conference, 2018, Jaipur

National and International Conference Presentations

• Is exon 19 deletion different from exon 21 mutation in advanced non-small cell lung cancer: a single center experience – ESMO ASIA, SINGAPORE, NOVEMBER 2019
• Trastuzumab chemotherapy in non-metastatic breast cancer: a real world situation – ESMO BREAST CONGRESS, BERLIN, GERMANY 2019
• Clinico-pathological Profile, Treatment and Outcomes of Metabolic Gastric Cancer: An Institutional Experience – 40TH ICON CONFERENCE, KOLKATA 2019
• Anaplastic lymphoma kinase positive advanced nsclc: an institutional experience -ISMPOCON JAIPUR 2018

Edition

• Comparison of weekly cisplatin with three-weekly cisplatin with adjuvant radiation in localized head and neck cancers, PACIFIC JOURNAL OF SCIENCES 2016
• Trastuzumab-related cardiomyopathy in the adjuvant setting: a real-world case, accepted for publication in the SOUTH ASIA JOURNAL OF CANCER
• Comparison of weekly cisplatin with three-weekly cisplatin with adjuvant radiation in localized head and neck cancer.

Membership

• Member, European Society for Oncology (ESMO)
• Member, Association of Radiation Oncologists of India (AROI)

Publications

Dr Sarita Shrivastva has authored several national and international publication including –

• Clinico-pathological profile, treatment and outcomes of metatstatic gastric cancer: An institutional experience
• Is Exon 19 deletion different from exon 21 mutation in advanced non-small cell lung cancer: A single center experience
• Trastuzumab related cardiotoxicity in nonmetastatic breast cancer: a real-world scenario
• Anaplastic Lymphoma Kinase positive advanced NSCLC – An institutional experience
• Comparison of weekly Cisplatin with three weekly Cisplatin with concurrent Radiation in locally advanced head and neck cancers
• Trastuzumab related cardiotoxicity in adjuvant setting: A real world Scenario

Languages

• English
• Telugu
• Hindi

Dr. Shrivastva’s association with the Medicover Cancer Institute highlights her dedication to delivering advanced oncological treatments. Her affiliation demonstrates a commitment to utilizing state-of-the-art facilities and resources to ensure the highest standard of care for her patients. Through this partnership, she aims to provide comprehensive and innovative solutions in the fight against cancer.